Abstract:Abstract BACKGROUND AND AIMS Lupus nephritis (LN) is the most serious organ manifestation of systemic lupus erythematosus (SLE), occurring in 40%–60% of subjects with SLE with worse outcomes. LN is mediated by antibody deposition in glomeruli, but the mechanisms leading to the immune deposits and renal lesions are not clarified. Previous findings suggested a role for circulating anti–double stranded DNA (dsDNA). However, anti-DNA deposition in LN accounts for not more than 10%–20% of eluted IgG. Therefore, renal targets of autoimmunity in LN are largely unknown. METHOD We studied 1052 patients with SLE, 459 with and 573 without LN, enrolled at different times from diagnosis (0–1 month, 2–12 m, 13–24 m, 25–48 m, 48–96 m and > 96m). These cohorts are part of a nation-wide study (The Zeus study, NCT02403115) to characterize the antibody multi-components in SLE and LN. A total of 92 LN patients recruited at T0, had a follow-up of 36 months. Laser capture microdissection were performed from fresh frozen renal samples of 20 patients with LN (classes III–V), and eluted Igs were analyzed by Western blot using podocyte extracts as fixed antigens. Recognized proteins were characterized by matrix-assisted laser desorption ionization (MALDI)–mass spectrometry (MS) and liquid chromatography (LC)-MS. Levels of anti-dsDNA, anti-ENO1, anti-AnnexinA1, anti-SOD, anti-C1q, anti-H2A histone were determined using non-commercial ELISA. RESULTS Glomerular IgGs recognized 11 proteins (Fig. 1A), which resulted positive also in serum of same subjects (Fig. 1B). Isotype analysis of glomerular eluates showed prevalence of IgG2 for anti-dsDNA, anti-Histone H2, anti-C1q, anti–α-enolase and anti-Annexin AI (Fig. 1C). Fig. 1D shows representative images of patients with LN class V: colocalization with IgG2 is positive for dsDNA, Histone H2, C1qα-enolase and annexin. Prevalence of IgG2 for the same proteins were confirmed also in serum samples of the same subjects (Fig. 1E). The presence in the serum of the IgG2 panel was highly discriminatory for SLE/LN versus healthy subjects (Fig. 2A). Heat map in Fig. 2B reports the association between the levels of circulating IgG2 antibodies and the clinical parameters for both LN and SLE together. While in Fig. 2C, the heat maps indicate the correlation between two parameters (an antibody and an organ pathology). Volcano plots indicate that anti-ENO1 and anti-Histone H2 IgG2 had the most significant changes in LN patients. In the prospective analysis, considering the 91 LN with 36 months of follow-up, decrements of each antibody at T12 related to proteinuria are summarized in Fig. 2E: major decrements were for anti-ENO1 and anti-Annexin A1 (−55% and − 70%, respectively) and 0% for anti-dsDNA. Serum levels of anti-SOD IgG2 at T0 resulted significantly higher in LN compared to SLE (Fig. 2F). The kinetics of reduction of anti-SOD IgG2 was in accordance with reduction of proteinuria (Fig. 2G). Of interest, anti-dsDNA IgG2 serum levels persistently maintained at high values during the same period (Fig. 2H). CONCLUSION Our study demonstrated higher sensitivity of anti-dsDNA IgG2 than classical IgGs antibodies for marginal SLE diagnosis. Positivity for the whole panel of circulating IgG2 antibodies is a specific signature of SLE/LN and distinguishes them from healthy people. Moreover, anti-ENO1 and anti-Histone H2 IgG2 serum levels represent the best discriminatory element for distinguishing between LN and SLE. From prospective analysis, we report that circulating anti-ENO1 IgG2 may represent a valuable markers of remittent LN. Similarly, circulating anti-SOD2 IgG2 are elevated in new onset LN. It might be hypothesized that increase is related to the activation of SOD2, as response to the oxidative stress induced by the active disease.

[Protein-analytical studies on the serum and urine of patients with visceral lupus erythematosus]

Serum level of anti-α-enolase antibody in untreated systemic lupus erythematosus patients correlates with 24-hour urine protein and D-dimer

Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods

Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases

Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis

Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE)

Different Roles of Urinary Light Chains and Serum Light Chains As Potential Biomarkers for Monitoring Disease Activity in Systemic Lupus Erythematosus.

Glomerular and tubular membrane antigens reflecting cellular adaptation in human renal failure

Significance of urinary albumin in patients with systemic lupus erythematosus

MO263: Multi-Antibody Composition in Lupus Nephritis: Isotype Prevalence and Clinical Oucome

Characterization of Anti-Mesangial Cell Antibodies and Their Target Antigens in Patients with Lupus Nephritis.

Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis

Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases

Exploring Serum Protein Biomarkers of Lupus Nephritis by Using Two-Dimensional Gel Electrophoresis Com-bined with Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry

Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis

Non-DNA-Binding Antibodies in Patients with Lupus Nephritis Could Recognize Membrane Proteins of Glomerular Mesangial Cells

Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis

Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus

iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus

Serum IgE Anti-Dsdna Autoantibodies in Patients with Proliferative Lupus Nephritis Are Associated with Tubulointerstitial Inflammation

Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods